Back
ESC Premium Access

Safety and efficacy of sacubitril/valsartan by dose level in patients hospitalized with acute heart failure: Observations from PIONEER-HF

Session: Acute heart failure : new treatment updates
Topic: Pharmacotherapy
Speaker: Professor D. Morrow (Boston, US)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor David Morrow

Brigham and Women's Hospital, Boston (United States of America)
8 presentations
3 followers

4 more presentations in this session

Short-term effects of dapagliflozin versus canagliflozin on acute decompensated heart failure in patients with type 2 diabetes

Speaker: Doctor M. Nakagaito (Toyama, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Mega-studies in heart failure, effect dilution in examination of new therapies.

Speaker: Doctor S. Senger (Durham, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Effect of empagliflozin as add-on therapy on decongestion and renal function in diabetic patients hospitalized for acute decompensated heart failure: a prospective randomized controlled study

Speaker: Mr S. Tamaki (Ehime, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Benefit of sinus rhythm restoration in acute decompensated heart failure patients with atrial tachyarrhythmia treated with landiolol

Speaker: Doctor M. Sakai (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Access the full session

Acute heart failure : new treatment updates

Speakers: Professor D. Morrow, Doctor M. Nakagaito, Doctor S. Senger, Mr S. Tamaki, Doctor M. Sakai
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources